Search

Your search keyword '"Cristina M Ghiuzeli"' showing total 2 results
Start Over Author "Cristina M Ghiuzeli"
2 results on '"Cristina M Ghiuzeli"'

1. Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir

Author

Emily S Ford, William Simmons, Ellora N Karmarkar, Leah H Yoke, Ayodale B Braimah, Johnnie J Orozco, Cristina M Ghiuzeli, Serena Barnhill, Coralynn L Sack, Joshua O Benditt, Pavitra Roychoudhury, Alexander L Greninger, Adrienne E Shapiro, Jennifer L Hammond, James M Rusnak, Mikael Dolsten, Michael Boeckh, Catherine Liu, Guang-Shing Cheng, and Lawrence Corey

Subjects
Microbiology (medical), Infectious Diseases
Abstract

A patient with B-cell acute lymphoblastic leukemia (ALL) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had persistent, progressive pneumonia with viremia after 5 months of infection despite monoclonal antibodies, intravenous (IV) remdesivir and prolonged oral steroids. Twenty days of nirmatrelvir/ritonavir and 10 days of IV remdesivir led to full recovery.

Published
2022

2. Successful treatment of prolonged, severe COVID-19 lower respiratory tract disease in a B-cell ALL patient with an extended course of remdesivir and nirmatrelvir/ritonavir

Author

Emily S, Ford, William, Simmons, Ellora N, Karmarkar, Leah H, Yoke, Ayodale B, Braimah, Johnnie J, Orozco, Cristina M, Ghiuzeli, Serena, Barnhill, Coralynn L, Sack, Joshua O, Benditt, Pavitra, Roychoudhury, Alexander L, Greninger, Adrienne E, Shapiro, Jennifer L, Hammond, James M, Rusnak, Mikael, Dolsten, Michael, Boeckh, Catherine, Liu, Guang-Shing, Cheng, and Lawrence, Corey

Abstract

A patient with B-cell acute lymphoblastic leukemia (ALL) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had persistent, progressive pneumonia with viremia after 5 months of infection despite monoclonal antibodies, IV remdesivir and prolonged oral steroids. Twenty days of nirmatrelvir/ritonavir and 10 days of IV remdesivir led to full recovery.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results